David Heuzé
Head of Corporate & Financial Communications and ESG

Hello, everyone. Thank you for joining our online R&D Day. If you wish to follow along the presentation, the slides are available on our website. Before we start, I would like to draw your attention to Slide 2, which contains important information regarding forward-looking statements.

Please note that today's discussion may include projections and assumptions, and we therefore encourage you to review this information carefully. After the presentations, we will open the floor for a Q&A session.

And with that, I am very pleased to invite Christophe Douat, our Chief Executive Officer, to open today's meeting. Christophe?

Christophe Douat
CEO & Director

Thank you, David. This is a very special moment for us. Good morning, everyone. Welcome, and thank you for joining us today for our R&D Day. Today is about one fundamental idea: how we turn science into long-term value creation. At MedinCell, innovation is not an abstract concept. It is something very tangible, something that reaches patients, supports physicians and ultimately transforms lives. And what we are building here is much bigger than individual products. We are building a platform, a model, a company designed to create value over the long term.

We are deeply proud of what